Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EADO 2020 | Access to novel therapies in melanoma

Bettina Ryll • 14 Oct 2020
EADO 2020
Skin Cancer

Bettina Ryll, MD, PhD, Melanoma Patient Network Europe, Uppsala, Sweden, outlines the importance of access to novel therapies and new treatment approaches for patients with melanoma, ensuring that scientific advances are helping the patients they are designed for. Dr Ryll also highlights language barriers as a challenge in accessing new therapies. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Bettina Ryll

Impact of COVID-19 on melanoma treatment
3:02
Impact of COVID-19 on melanoma treatment
Bettina Ryll • 13 Oct 2020
Melanoma Patient Network Europe
2:12
Melanoma Patient Network Europe
Bettina Ryll • 14 Oct 2020
ECCO 2017: treatment value vs affordability
2:05
ECCO 2017: treatment value vs affordability
Bettina Ryll • 27 Jan 2017
The Medicines Adaptive Pathways to Patients (MAPPs) and its importance in oncology
1:03
The Medicines Adaptive Pathways to Patients (MAPPs) and its importance in oncology
Bettina Ryll • 7 Oct 2016

Related Videos

BRAF/MEK inhibition prior to immunotherapy in melanoma: insights from the COWBOY trial
1:45
BRAF/MEK inhibition prior to immunotherapy in melanoma: insights from the COWBOY trial
Kalijn Bol • 31 May 2026
COWBOY trial: optimal sequencing of BRAF/MEK inhibition and immunotherapy in BRAF-mutated melanoma
1:08
COWBOY trial: optimal sequencing of BRAF/MEK inhibition and immunotherapy in BRAF-mutated melanoma
Kalijn Bol • 31 May 2026
Could induction BRAF/MEK inhibition be useful for some melanoma patients with metastases?
1:02
Could induction BRAF/MEK inhibition be useful for some melanoma patients with metastases?
Kalijn Bol • 31 May 2026
The future of personalized and off-the-shelf mRNA vaccines in melanoma
1:02
The future of personalized and off-the-shelf mRNA vaccines in melanoma
James Smithy • 31 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals